Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_49491 | 136 | 2.83 | Mlig455_054796 | Neo: - Age: - Region-enriched R2: 7.065/0.00003 |
Mlig455_054796 {REF} {Length: 1567} {RNA1509_22234} {RNA1310_23973} {RNA815_10832} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -3.511 | 2.33 | 0.99979 | 1.00000 | |
RegionR2 | 7.065 | 2.33 | 0.00000 | 0.00003 | |
RegionR3 | 1.676 | 2.33 | 0.25313 | 0.79723 | |
RegionR4 | -0.529 | 2.33 | 0.80327 | 1.00000 | |
RegionR5 | 0.249 | 2.33 | 0.65604 | 1.00000 | |
RegionR6 | 0.065 | 2.33 | 0.71110 | 1.00000 | |
RegionR7 | -2.493 | 2.33 | 0.99956 | 1.00000 | |
RegionR8 | -2.521 | 2.33 | 0.99960 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -0.193 | 2.33 | 0.99998 | 1.00000 | |
RegenerationR2 | -0.626 | 2.33 | 0.28601 | 0.72884 | |
RegenerationR3 | -0.892 | 2.33 | 0.45994 | 0.83752 | |
RegenerationR4 | -0.895 | 2.33 | 0.51139 | 0.87509 | |
RegenerationR5 | -1.613 | 2.33 | 0.25150 | 0.68488 | |
RegenerationR6 | 0.374 | 2.33 | 0.78501 | 0.97006 | |
RegenerationBL | -1.468 | 2.33 | 0.99968 | 1.00000 | |
RegenerationTP | 4.194 | 2.33 | 0.11147 | 0.51319 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_49491 | 136 | 2.83 | Mlig455_054796 | Neo: - Age: - Region-enriched R2: 7.065/0.00003 |
6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_054796 {REF} {Length: 1567} {RNA1509_22234} {RNA1310_23973} {RNA815_10832} | |
2. | MligTC455_33040 | 203 | 4.23 | Mlig455_032497 | Neo: - Age: logFC(26M/2M)=0.515 Region-enriched R2: 4.005/0.00408 |
PKD2L1 | 5.709 | 0.816 | 0.939 | 0.996 | 0.989 | 0.986 | 0.983 | Mlig455_032497 {REF} {Length: 3318} {Pfam: Polycystin cation channel [PF08016.14, score=293.1]; Ion transport protein [PF00520.33, score=39.7]} {Human: ENSG00000107593, PKD2L1, polycystin 2 like 1, transient receptor potential cation channel, [Score=236, Expect=4e-66]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=261, Expect=3e-73]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=131, Expect=5e-31]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=180, Expect=1e-47]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=641, Expect=0.0]} {RNA1509_3444} {RNA1310_89} {RNA815_1814} |
3. | MligTC455_19276 | 1694 | 35.28 | Mlig455_057303 | Neo: - Age: Down-Down-Up Region-specific R2: 5.711 Region-enriched R2: 6.117/0.00000 |
5.626 | 0.899 | 0.974 | 0.892 | 0.923 | 0.952 | 0.986 | Mlig455_057303 {REF} {Length: 1196} {Pfam: TATA-binding related factor (TRF) of subunit 20 of Mediator complex [PF08612.13, score=80.6]} {Smed: dd_Smed_v6_9879_0_1, dd_Smed_v6_9879_0_1, [RH, Score=73.9, Expect=1e-15]} {RNA1509_58478} {RNA1310_35292} {RNA815_20171} | |
4. | MligTC455_42376 | 61 | 1.27 | Mlig455_069890 | Neo: - Age: - |
5.624 | 0.860 | 0.932 | 0.962 | 0.955 | 0.979 | 0.936 | Mlig455_069890 {REF} {Length: 630} {TRANSSPLICED} {Pfam: PAN domain [PF00024.28, score=26.1]} {RNA1509_53783} {RNA1310_37190} {RNA815_24434} | |
5. | MligTC455_38682 | 102 | 2.12 | Mlig455_039641 | Neo: - Age: - Region-enriched R2: 6.138/0.02363 |
SLC18A3 | 5.614 | 0.864 | 0.981 | 0.981 | 0.977 | 0.840 | 0.971 | Mlig455_039641 {REF} {Length: 3925} {Pfam: Major Facilitator Superfamily [PF07690.18, score=147.1]; Sugar (and other) transporter [PF00083.26, score=29.0]; LacY proton/sugar symporter [PF01306.21, score=20.2]} {Human: ENSG00000187714, SLC18A3, solute carrier family 18 member A3, [RH, Score=469, Expect=9e-161]} {Mouse: ENSMUSG00000100241, Slc18a3, solute carrier family 18 (vesicular monoamine), member 3, [RH, Score=469, Expect=1e-160]} {Dmel: FBgn0270928, VAChT, Vesicular acetylcholine transporter, [RH, Score=513, Expect=2e-177]} {Celegans: WBGene00006756, unc-17, Vesicular acetylcholine transporter unc-17, [RH, Score=486, Expect=2e-167]} {Smed: dd_Smed_v6_11630_0_1, dd_Smed_v6_11630_0_1, [RH, Score=563, Expect=0.0]} {RNA1310_28397} {RNA815_32284.1} |
6. | MligTC455_33039 | 312 | 6.51 | Mlig455_032494 | Neo: - Age: Up-Down-Down Region-enriched R2: 3.545/0.00267 |
PKDREJ | 5.598 | 0.847 | 0.880 | 0.961 | 0.981 | 0.952 | 0.977 | Mlig455_032494 {REF} {Length: 11952} {Pfam: Polycystin cation channel [PF08016.14, score=289.9]; REJ domain [PF02010.17, score=90.4]; PLAT/LH2 domain [PF01477.25, score=68.4]; PKD domain [PF00801.22, score=57.9]; PKD domain [PF18911.2, score=36.7]; Ion transport protein [PF00520.33, score=36.3]; GPCR proteolysis site, GPS, motif [PF01825.23, score=30.0]; WSC domain [PF01822.21, score=23.3]} {Human: ENSG00000130943, PKDREJ, polycystin family receptor for egg jelly, [Score=267, Expect=1e-70]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=292, Expect=3e-78]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=136, Expect=2e-31]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [RH, Score=297, Expect=4e-80]} {Smed: dd_Smed_v6_15525_0_1, dd_Smed_v6_15525_0_1, [Score=1504, Expect=0.0]} {RNA1509_3444} {RNA1310_89} {RNA815_1814} |
7. | MligTC455_19277 | 1013 | 21.11 | Mlig455_059600 | Neo: - Age: - Region-specific R2: 4.883 Region-enriched R2: 5.766/0.00000 |
5.582 | 0.841 | 0.977 | 0.971 | 0.874 | 0.961 | 0.958 | Mlig455_059600 {REF} {Length: 827} {NoTransDecoderORF} {RNA1509_43907} {RNA1310_81348} | |
8. | MligTC455_19278 | 4335 | 90.31 | Mlig455_057304, Mlig455_070944 | Neo: - Age: logFC(26M/2M)=0.686 Region-specific R2: 5.590 Region-enriched R2: 5.465/0.00000 |
CHRNA10 | 5.578 | 0.891 | 0.975 | 0.839 | 0.940 | 0.947 | 0.986 | Mlig455_057304 {REF} {Length: 1001} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=71.6]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=77.0, Expect=2e-16]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=75.9, Expect=4e-16]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=75.5, Expect=6e-16]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=73.9, Expect=2e-15]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=93.6, Expect=2e-22]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=100, Expect=5e-25]} {Smed: dd_Smed_v6_11955_0_1, dd_Smed_v6_11955_0_1, [Score=82.8, Expect=8e-19]} {RNA1509_23115} {RNA1310_34970} {RNA815_15305.1} Mlig455_070944 {REF} {Length: 1060} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=88.2]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=95.9, Expect=6e-22]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=96.3, Expect=3e-22]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=94.7, Expect=1e-21]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=112, Expect=7e-28]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=118, Expect=4e-30]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=98.6, Expect=2e-23]} {RNA1509_23115, RNA1509_43907, RNA1509_9432} {RNA1310_34970, RNA1509_23115, RNA1509_43907, RNA1509_9432} {RNA1509_23115, RNA1509_43907, RNA1509_9432, RNA815_15305.1} |
9. | MligTC455_39481 | 461 | 9.6 | Mlig455_056703, Mlig455_060318 | Neo: - Age: Down-Up-Up Region-specific R2: 4.222 |
ANGPTL1 | 5.548 | 0.911 | 0.853 | 0.904 | 0.912 | 0.972 | 0.996 | Mlig455_056703 {REF} {Length: 1114} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=79.0]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=89.4, Expect=1e-19]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=85.1, Expect=3e-18]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=91.3, Expect=2e-20]} {Dmel: FBgn0033312, CG8642, [Score=82.4, Expect=1e-17]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=76.3, Expect=1e-15]} {RNA1310_31288} {RNA815_20497.1} Mlig455_060318 {REF} {Length: 1175} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=112.7]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=106, Expect=2e-25]; ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=105, Expect=6e-26]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=109, Expect=1e-26]} {Dmel: FBgn0034160, CG5550, [Score=96.3, Expect=2e-23]} {Celegans: WBGene00016769, C49C8.5, [Score=47.0, Expect=9e-06]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=88.2, Expect=2e-19]} {RNA1310_31288} {RNA815_20497.1} |
10. | MligTC455_49307 | 122 | 2.55 | Mlig455_055230 | Neo: - Age: - Region-enriched R2: 4.447/0.04819 |
ZAN | 5.538 | 0.970 | 0.846 | 0.932 | 0.984 | 0.886 | 0.920 | Mlig455_055230 {REF} {Length: 2947} {Pfam: Glycine rich protein [PF12810.9, score=28.6]} {Human: ENSG00000146839, ZAN, zonadhesin (gene/pseudogene), [Score=79.7, Expect=1e-14]} {Mouse: ENSMUSG00000079173, Zan, zonadhesin, [Score=80.1, Expect=7e-15]} {RNA1310_18897} {RNA815_40026} |
11. | MligTC455_40852 | 128 | 2.66 | Mlig455_042301 | Neo: - Age: Up-Up-Down, logFC(26M/2M)=0.671 Region-enriched R2: 6.158/0.00357 |
PKDREJ | 5.536 | 0.969 | 0.792 | 0.917 | 0.950 | 0.933 | 0.975 | Mlig455_042301 {REF} {Length: 11184} {Pfam: Polycystin cation channel [PF08016.14, score=273.5]; PKD domain [PF00801.22, score=86.2]; PLAT/LH2 domain [PF01477.25, score=67.1]; REJ domain [PF02010.17, score=66.8]; PKD domain [PF18911.2, score=62.3]; Ion transport protein [PF00520.33, score=45.4]} {Human: ENSG00000130943, PKDREJ, polycystin family receptor for egg jelly, [Score=283, Expect=2e-75]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=273, Expect=2e-72]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=158, Expect=3e-38]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=254, Expect=4e-67]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=514, Expect=2e-146]} {RNA1509_8046} {RNA1310_93, RNA1509_8046} {RNA1509_8046, RNA815_1216} |
12. | MligTC455_16415 | 197 | 4.1 | Mlig455_000401 | Neo: - Age: - Region-enriched R2: 4.276/0.00982 |
ROR1 | 5.52 | 0.940 | 0.889 | 0.910 | 0.871 | 0.912 | 0.998 | Mlig455_000401 {REF} {Length: 3780} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=233.3]; Protein kinase domain [PF00069.27, score=85.9]; Immunoglobulin I-set domain [PF07679.18, score=49.4]; Immunoglobulin domain [PF13927.8, score=46.6]; Immunoglobulin domain [PF00047.27, score=31.9]; Immunoglobulin domain [PF13895.8, score=30.0]; Fz domain [PF01392.24, score=27.6]; Kringle domain [PF00051.20, score=22.3]; Immunoglobulin V-set domain [PF07686.19, score=19.5]} {Human: ENSG00000185483, ROR1, receptor tyrosine kinase like orphan receptor 1, [RH, Score=390, Expect=1e-119]; ENSG00000169071, ROR2, receptor tyrosine kinase like orphan receptor 2, [RH, Score=379, Expect=1e-115]} {Mouse: ENSMUSG00000035305, Ror1, receptor tyrosine kinase-like orphan receptor 1, [RH, Score=386, Expect=1e-118]; ENSMUSG00000021464, Ror2, receptor tyrosine kinase-like orphan receptor 2, [RH, Score=377, Expect=4e-115]} {Dmel: FBgn0010407, Ror, [Score=286, Expect=3e-84]} {Celegans: WBGene00000289, cam-1, Tyrosine-protein kinase receptor cam-1, [Score=285, Expect=4e-82]} {Smed: dd_Smed_v6_7911_0_1, dd_Smed_v6_7911_0_1, [RH, Score=439, Expect=2e-139]} {RNA1509_35395} {RNA1310_13558, RNA1509_35395} {RNA1509_35395, RNA815_27446} |
13. | MligTC455_42510 | 125 | 2.6 | Mlig455_025998, Mlig455_070424 | Neo: - |
5.501 | 0.832 | 0.818 | 0.938 | 0.931 | 0.985 | 0.997 | Mlig455_025998 {REF} {Length: 1369} {RNA1310_73875.1} Mlig455_070424 {REF} {Length: 1082} {RNA1310_73875.1} |
|
14. | MligTC455_20443 | 430 | 8.96 | Mlig455_010917, Mlig455_033173 | Neo: - Age: - Region-specific R2: 4.126 Region-enriched R2: 3.438/0.00019 |
CFAP77 | 5.49 | 0.937 | 0.782 | 0.965 | 0.948 | 0.940 | 0.918 | Mlig455_010917 {REF} {Length: 1338} {Pfam: Domain of unknown function (DUF4483) [PF14825.8, score=38.6]} {Human: ENSG00000188523, CFAP77, cilia and flagella associated protein 77, [Score=47.8, Expect=3e-06]} {Mouse: ENSMUSG00000079502, Cfap77, cilia and flagella associated protein 77, [Score=50.1, Expect=4e-07]} {Smed: dd_Smed_v6_5179_0_1, dd_Smed_v6_5179_0_1, [Score=84.3, Expect=4e-20]} {RNA1509_46220} {RNA1310_36457, RNA1509_46220} {RNA1509_46220, RNA815_17196} Mlig455_033173 {REF} {Length: 978} {TRANSSPLICED} {Pfam: Domain of unknown function (DUF4483) [PF14825.8, score=19.5]} {RNA1509_46220} {RNA1310_36457} {RNA815_17196} |
15. | MligTC455_34369 | 112 | 2.34 | Mlig455_015308, Mlig455_015354, Mlig455_036248, Mlig455_068737, Mlig455_070110 | Neo: - Age: Up-Down-Up Region-enriched R2: 5.462/0.00546 |
5.487 | 0.816 | 0.979 | 0.996 | 0.966 | 0.869 | 0.861 | Mlig455_015308 {REF} {Length: 1459} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=63.9]} {RNA1310_34740} {RNA815_15663} Mlig455_015354 {REF} {Length: 1446} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=66.3]; Sialidase, N-terminal domain [PF02973.18, score=18.5]} {RNA1310_34740} {RNA815_15663} Mlig455_036248 {REF} {Length: 2111} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=120.9]; Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=28.5]; PAN domain [PF00024.28, score=19.9]} {RNA1509_45496} {RNA1310_2539.1} {RNA815_252.1} Mlig455_068737 {REF} {Length: 1096} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=68.3]; Sialidase, N-terminal domain [PF02973.18, score=19.9]} {RNA1310_34740} {RNA815_37905} Mlig455_070110 {REF} {Length: 1340} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=109.6]} {RNA1509_32599} {RNA1310_1659} {RNA815_252.1} |
|
16. | MligTC455_21757 | 26 | 0.53 | Mlig455_057867 | Neo: - Age: - |
5.486 | 0.984 | 0.848 | 0.763 | 0.924 | 0.967 | 1.000 | Mlig455_057867 {REF} {Length: 284} {NoTransDecoderORF} {RNA1310_117997} | |
17. | MligTC455_21755 | 70 | 1.47 | Mlig455_021213 | Neo: - Age: - |
5.48 | 0.927 | 0.956 | 0.875 | 0.854 | 0.871 | 0.997 | Mlig455_021213 {REF} {Length: 4215} {Pfam: F5/8 type C domain [PF00754.27, score=55.5]} {RNA1509_2515} {RNA1310_33166} {RNA815_14716} | |
18. | MligTC455_34524 | 155 | 3.22 | Mlig455_021291 | Neo: - Age: Down-Up-Down Region-specific R2: 4.905 Region-enriched R2: 4.200/0.01842 |
5.48 | 0.811 | 0.968 | 0.973 | 0.830 | 0.917 | 0.981 | Mlig455_021291 {REF} {Length: 1478} {NoTransDecoderORF} {RNA1509_56543} {RNA1310_26920, RNA1509_56543} {RNA1509_56543, RNA815_11718} | |
19. | MligTC455_27025 | 706 | 14.7 | Mlig455_054786, Mlig455_054878 | Neo: - Age: - Region-enriched R2: 3.519/0.00005 |
CD82 | 5.478 | 0.864 | 0.903 | 0.887 | 0.986 | 0.911 | 0.927 | Mlig455_054786 {REF} {Length: 2796} {Pfam: Tetraspanin family [PF00335.22, score=142.8]} {Human: ENSG00000085117, CD82, CD82 molecule, [RH, Score=86.3, Expect=4e-19]} {Mouse: ENSMUSG00000027215, Cd82, CD82 antigen, [RH, Score=94.0, Expect=3e-22]} {Dmel: FBgn0035936, Tsp66E, Tetraspanin 66E, [Score=98.6, Expect=6e-24]} {Celegans: WBGene00006632, tsp-6, Tetraspanin, [Score=74.7, Expect=1e-15]} {Smed: dd_Smed_v6_13639_0_1, dd_Smed_v6_13639_0_1, [RH, Score=160, Expect=2e-47]} {RNA1509_20389, RNA1509_43644, RNA1509_56428} {RNA1310_8032.1, RNA1509_20389, RNA1509_43644, RNA1509_56428} {RNA1509_20389, RNA1509_43644, RNA1509_56428, RNA815_3380.1} Mlig455_054878 {REF} {Length: 4398} {Pfam: Tetraspanin family [PF00335.22, score=143.7]} {Human: ENSG00000085117, CD82, CD82 molecule, [RH, Score=84.7, Expect=2e-18]} {Mouse: ENSMUSG00000027215, Cd82, CD82 antigen, [RH, Score=92.4, Expect=2e-21]} {Dmel: FBgn0035936, Tsp66E, Tetraspanin 66E, [Score=99.8, Expect=4e-24]} {Celegans: WBGene00006643, tsp-17, TetraSPanin family, [RH, Score=73.2, Expect=1e-14]} {Smed: dd_Smed_v6_13639_0_1, dd_Smed_v6_13639_0_1, [RH, Score=160, Expect=2e-47]} {RNA1509_56428} {RNA1310_8032.2} {RNA815_3380.1} |
20. | MligTC455_39988 | 83 | 1.73 | Mlig455_062081 | Neo: - Age: - |
5.461 | 0.852 | 0.817 | 0.992 | 0.999 | 0.801 | 1.000 | Mlig455_062081 {REF} {Length: 447} {NoTransDecoderORF} {RNA1509_50426} {RNA1310_88257} {RNA815_17173.4} | |
21. | MligTC455_47080 | 362 | 7.54 | Mlig455_037356 | Neo: - Age: - Region-enriched R2: 2.691/0.00566 |
SSUH2 | 5.418 | 0.927 | 0.948 | 0.743 | 0.984 | 0.821 | 0.995 | Mlig455_037356 {REF} {Length: 1984} {Pfam: DnaJ central domain [PF00684.21, score=20.9]} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=189, Expect=3e-56]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=156, Expect=5e-44]} {Celegans: WBGene00013455, ssu-2, Suppressor of Stomatin mutant Uncoordination, [Score=90.9, Expect=7e-20]} {RNA1509_29510} {RNA1310_15488, RNA1509_29510} {RNA1509_29510, RNA815_5650} |
22. | MligTC455_16416 | 290 | 6.04 | Mlig455_000468 | Neo: - Age: - Region-enriched R2: 2.225/0.04782 |
ROR1 | 5.404 | 0.878 | 0.932 | 0.861 | 0.828 | 0.920 | 0.985 | Mlig455_000468 {REF} {Length: 2686} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=208.1]; Protein kinase domain [PF00069.27, score=77.3]; Kringle domain [PF00051.20, score=19.4]} {Human: ENSG00000185483, ROR1, receptor tyrosine kinase like orphan receptor 1, [Score=300, Expect=1e-89]} {Mouse: ENSMUSG00000035305, Ror1, receptor tyrosine kinase-like orphan receptor 1, [Score=295, Expect=2e-87]; ENSMUSG00000021464, Ror2, receptor tyrosine kinase-like orphan receptor 2, [Score=281, Expect=2e-82]} {Dmel: FBgn0010407, Ror, [Score=259, Expect=2e-76]} {Celegans: WBGene00000289, cam-1, Tyrosine-protein kinase receptor cam-1, [Score=217, Expect=2e-60]} {Smed: dd_Smed_v6_7911_0_1, dd_Smed_v6_7911_0_1, [Score=328, Expect=1e-100]} {RNA1509_35395} {RNA1310_13558} {RNA815_27446} |
23. | MligTC455_16749 | 454 | 9.45 | Mlig455_001550, Mlig455_046548 | Neo: - Age: logFC(26M/2M)=0.515 Region-specific R2: 4.360 Region-enriched R2: 3.409/0.00015 |
TRAF4 | 5.359 | 0.861 | 0.732 | 0.968 | 0.948 | 0.888 | 0.962 | Mlig455_001550 {REF} {Length: 4563} {Pfam: TRAF-type zinc finger [PF02176.20, score=81.2]; Zinc finger, C3HC4 type (RING finger) [PF13923.8, score=27.3]; Seven in absentia protein family [PF03145.18, score=27.2]; Zinc finger, C3HC4 type (RING finger) [PF00097.27, score=23.0]; Zinc finger, C3HC4 type (RING finger) [PF13920.8, score=22.9]; zinc finger of C3HC4-type, RING [PF15227.8, score=20.4]; zf-RING of BARD1-type protein [PF14835.8, score=20.3]; Ring finger domain [PF13639.8, score=19.5]} {Human: ENSG00000076604, TRAF4, TNF receptor associated factor 4, [Score=237, Expect=4e-72]} {Mouse: ENSMUSG00000017386, Traf4, TNF receptor associated factor 4, [Score=241, Expect=7e-74]} {Dmel: FBgn0026319, Traf4, TNF-receptor-associated factor 4, [Score=164, Expect=1e-44]} {Celegans: WBGene00006612, trf-1, TNF Receptor Associated Factor (TRAF) homolog; TRF-1, [RH, Score=276, Expect=1e-87]} {Smed: dd_Smed_v6_13517_0_1, dd_Smed_v6_13517_0_1, [RH, Score=592, Expect=0.0]} {RNA1509_20900} {RNA1310_14813, RNA1509_20900} {RNA1509_20900, RNA815_2335.1} Mlig455_046548 {REF} {Length: 3881} {Pfam: TRAF-type zinc finger [PF02176.20, score=81.2]; Zinc finger, C3HC4 type (RING finger) [PF13923.8, score=27.3]; Seven in absentia protein family [PF03145.18, score=27.2]; Zinc finger, C3HC4 type (RING finger) [PF00097.27, score=23.0]; Zinc finger, C3HC4 type (RING finger) [PF13920.8, score=22.9]; zinc finger of C3HC4-type, RING [PF15227.8, score=20.4]; zf-RING of BARD1-type protein [PF14835.8, score=20.3]; Ring finger domain [PF13639.8, score=19.5]} {Human: ENSG00000076604, TRAF4, TNF receptor associated factor 4, [Score=236, Expect=1e-71]} {Mouse: ENSMUSG00000017386, Traf4, TNF receptor associated factor 4, [Score=240, Expect=3e-73]} {Dmel: FBgn0026319, Traf4, TNF-receptor-associated factor 4, [Score=164, Expect=9e-45]} {Celegans: WBGene00006612, trf-1, TNF Receptor Associated Factor (TRAF) homolog; TRF-1, [RH, Score=275, Expect=6e-87]} {Smed: dd_Smed_v6_13517_0_1, dd_Smed_v6_13517_0_1, [RH, Score=592, Expect=0.0]} {RNA1509_20900} {RNA1310_14813} {RNA815_2335.1} |
24. | MligTC455_41368 | 369 | 7.68 | Mlig455_007683, Mlig455_020872, Mlig455_020918, Mlig455_020998 | Neo: - Age: - |
5.313 | 0.970 | 0.781 | 0.792 | 0.955 | 0.939 | 0.876 | Mlig455_007683 {REF} {Length: 1379} {RNA1310_25040.2} {RNA815_12562.1} Mlig455_020872 {REF} {Length: 1217} {RNA1310_25040.2} {RNA815_12562.1} Mlig455_020918 {REF} {Length: 1220} {RNA1310_25040.2} {RNA815_12562.1} Mlig455_020998 {REF} {Length: 1235} {RNA1310_25040.1} {RNA815_12562.1} |
|
25. | MligTC455_45350 | 92 | 1.93 | Mlig455_024760, Mlig455_058317, Mlig455_068656 | Neo: - Age: Up-Down-Down |
SLC17A6, SLC17A8 | 5.285 | 0.824 | 0.835 | 0.981 | 0.894 | 0.764 | 0.987 | Mlig455_024760 {REF} {Length: 2935} {Pfam: Major Facilitator Superfamily [PF07690.18, score=158.2]} {Human: ENSG00000179520, SLC17A8, solute carrier family 17 member 8, [RH, Score=531, Expect=0.0]; ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [RH, Score=531, Expect=0.0]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [RH, Score=522, Expect=5e-180]} {Mouse: ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [RH, Score=536, Expect=0.0]; ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [RH, Score=530, Expect=0.0]; ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [RH, Score=527, Expect=0.0]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=487, Expect=1e-165]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [RH, Score=474, Expect=3e-161]} {Smed: dd_Smed_v6_10192_0_1, dd_Smed_v6_10192_0_1, [RH, Score=583, Expect=0.0]} {RNA1310_14405.1} {RNA815_24257} Mlig455_058317 {REF} {Length: 2971} {Pfam: Major Facilitator Superfamily [PF07690.18, score=157.7]} {Human: ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [RH, Score=534, Expect=0.0]; ENSG00000179520, SLC17A8, solute carrier family 17 member 8, [RH, Score=531, Expect=0.0]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [RH, Score=521, Expect=8e-180]} {Mouse: ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [RH, Score=536, Expect=0.0]; ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [RH, Score=531, Expect=0.0]; ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [RH, Score=526, Expect=0.0]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=485, Expect=1e-164]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [Score=474, Expect=7e-162]} {Smed: dd_Smed_v6_10192_0_1, dd_Smed_v6_10192_0_1, [Score=585, Expect=0.0]} {RNA1310_14405.1} {RNA815_24257} Mlig455_068656 {REF} {Length: 3034} {Pfam: Major Facilitator Superfamily [PF07690.18, score=158.2]} {Human: ENSG00000179520, SLC17A8, solute carrier family 17 member 8, [RH, Score=531, Expect=0.0]; ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [RH, Score=531, Expect=0.0]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [RH, Score=522, Expect=5e-180]} {Mouse: ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [RH, Score=536, Expect=0.0]; ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [RH, Score=530, Expect=0.0]; ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [RH, Score=527, Expect=0.0]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=487, Expect=1e-165]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [RH, Score=474, Expect=3e-161]} {Smed: dd_Smed_v6_10192_0_1, dd_Smed_v6_10192_0_1, [RH, Score=583, Expect=0.0]} {RNA1310_14405.1} {RNA815_24257} |
26. | MligTC455_31164 | 572 | 11.91 | Mlig455_029609, Mlig455_045673 | Neo: - Age: - |
5.274 | 0.705 | 0.815 | 0.931 | 0.934 | 0.910 | 0.979 | Mlig455_029609 {REF} {Length: 746} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=39.4]} {Smed: dd_Smed_v6_22533_0_1, dd_Smed_v6_22533_0_1, [Score=48.5, Expect=1e-06]} {RNA1310_96354} {RNA815_44390} Mlig455_045673 {REF} {Length: 2025} {RNA1509_21720} {RNA1310_14760} {RNA815_24583} |
|
27. | MligTC455_54338 | 49 | 1.02 | Mlig455_056485 | Neo: - Age: Up-Down-Down |
PKDREJ | 5.246 | 0.880 | 0.793 | 0.899 | 0.743 | 0.945 | 0.986 | Mlig455_056485 {REF} {Length: 11174} {Pfam: Polycystin cation channel [PF08016.14, score=290.0]; REJ domain [PF02010.17, score=90.7]; PLAT/LH2 domain [PF01477.25, score=67.3]; PKD domain [PF00801.22, score=47.7]; Ion transport protein [PF00520.33, score=40.1]; PKD domain [PF18911.2, score=29.8]; GPCR proteolysis site, GPS, motif [PF01825.23, score=27.4]; WSC domain [PF01822.21, score=27.0]} {Human: ENSG00000130943, PKDREJ, polycystin family receptor for egg jelly, [Score=280, Expect=1e-74]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=307, Expect=8e-83]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=151, Expect=3e-36]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [RH, Score=302, Expect=1e-81]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [RH, Score=1844, Expect=0.0]} {RNA1509_16432} {RNA1310_1236} {RNA815_2411} |
28. | MligTC455_46823 | 69 | 1.44 | Mlig455_040455, Mlig455_042847 | Neo: - Age: - Region-enriched R2: 5.281/0.02950 |
ANGPTL2 | 5.218 | 0.970 | 0.731 | 0.847 | 0.722 | 0.996 | 0.952 | Mlig455_040455 {REF} {Length: 1444} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=152.3]} {Human: ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=129, Expect=8e-34]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=129, Expect=9e-34]; ENSG00000085265, FCN1, ficolin 1, [Score=128, Expect=1e-34]; ENSG00000160339, FCN2, ficolin 2, [Score=125, Expect=1e-33]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=132, Expect=4e-35]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=129, Expect=6e-34]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=127, Expect=3e-33]} {Dmel: FBgn0033312, CG8642, [Score=117, Expect=4e-30]} {Celegans: WBGene00017013, ensh-1, [Score=55.1, Expect=2e-08]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=111, Expect=2e-27]} {RNA1509_26827} {RNA1310_31596.2} {RNA815_17173.3} Mlig455_042847 {REF} {Length: 1175} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=154.0]} {Human: ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=132, Expect=7e-35]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=132, Expect=1e-34]; ENSG00000085265, FCN1, ficolin 1, [Score=130, Expect=2e-35]; ENSG00000130812, ANGPTL6, angiopoietin like 6, [Score=126, Expect=1e-32]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=136, Expect=2e-36]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=132, Expect=5e-35]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=130, Expect=1e-34]} {Dmel: FBgn0033312, CG8642, [Score=117, Expect=4e-30]} {Celegans: WBGene00017013, ensh-1, [Score=57.4, Expect=3e-09]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=114, Expect=2e-28]} {RNA1509_26827} {RNA1310_31596.2} {RNA815_17173.3} |
29. | MligTC455_39890 | 162 | 3.37 | Mlig455_047281, Mlig455_047331, Mlig455_069333 | Neo: - Age: - Region-enriched R2: 6.097/0.00148 |
PLSCR1 | 5.199 | 0.722 | 0.722 | 0.895 | 0.866 | 0.996 | 0.998 | Mlig455_047281 {REF} {Length: 1404} {Pfam: Scramblase [PF03803.17, score=248.1]} {Human: ENSG00000188313, PLSCR1, phospholipid scramblase 1, [Score=225, Expect=4e-72]} {Mouse: ENSMUSG00000032369, Plscr1, phospholipid scramblase 1, [Score=227, Expect=5e-73]; ENSMUSG00000032372, Plscr2, phospholipid scramblase 2, [Score=222, Expect=3e-71]} {Dmel: FBgn0052056, scramb1, scramblase 1, [Score=223, Expect=6e-73]} {Celegans: WBGene00014200, scrm-2, Phospholipid scramblase, [Score=194, Expect=2e-61]} {Smed: dd_Smed_v6_16813_0_1, dd_Smed_v6_16813_0_1, [RH, Score=306, Expect=1e-104]} {RNA1310_29769} {RNA815_41335} Mlig455_047331 {REF} {Length: 1395} {Pfam: Scramblase [PF03803.17, score=248.1]} {Human: ENSG00000188313, PLSCR1, phospholipid scramblase 1, [Score=225, Expect=4e-72]} {Mouse: ENSMUSG00000032369, Plscr1, phospholipid scramblase 1, [Score=227, Expect=5e-73]; ENSMUSG00000032372, Plscr2, phospholipid scramblase 2, [Score=222, Expect=3e-71]} {Dmel: FBgn0052056, scramb1, scramblase 1, [Score=223, Expect=6e-73]} {Celegans: WBGene00014200, scrm-2, Phospholipid scramblase, [Score=194, Expect=2e-61]} {Smed: dd_Smed_v6_16813_0_1, dd_Smed_v6_16813_0_1, [RH, Score=306, Expect=1e-104]} {RNA1310_29769} {RNA815_41335} Mlig455_069333 {REF} {Length: 1416} {Pfam: Scramblase [PF03803.17, score=248.7]} {Human: ENSG00000188313, PLSCR1, phospholipid scramblase 1, [Score=226, Expect=1e-72]} {Mouse: ENSMUSG00000032369, Plscr1, phospholipid scramblase 1, [Score=228, Expect=2e-73]; ENSMUSG00000032372, Plscr2, phospholipid scramblase 2, [Score=223, Expect=1e-71]} {Dmel: FBgn0052056, scramb1, scramblase 1, [Score=224, Expect=2e-73]} {Celegans: WBGene00014200, scrm-2, Phospholipid scramblase, [Score=194, Expect=4e-61]} {Smed: dd_Smed_v6_16813_0_1, dd_Smed_v6_16813_0_1, [RH, Score=304, Expect=2e-103]} {RNA1310_29769} {RNA815_41335} |
30. | MligTC455_46438 | 147 | 3.07 | Mlig455_021783 | Neo: - Age: Up-Down-Down |
5.19 | 0.798 | 0.741 | 0.936 | 0.959 | 0.883 | 0.873 | Mlig455_021783 {REF} {Length: 2899} {RNA1509_36156} {RNA1310_17582, RNA1509_36156} {RNA1509_36156, RNA815_32277} | |
31. | MligTC455_52570 | 71 | 1.49 | Mlig455_066071 | Neo: - Age: Up-Down-Up |
5.167 | 0.725 | 0.792 | 0.997 | 0.879 | 0.774 | 1.000 | Mlig455_066071 {REF} {Length: 2575} {Pfam: Hemingway/CFA97 [PF13879.8, score=54.6]; Annexin [PF00191.22, score=26.1]} {Mouse: ENSMUSG00000090336, Cfap97d2, CFAP97 domain containing 2, [Score=46.6, Expect=3e-06]} {Smed: dd_Smed_v6_2676_0_1, dd_Smed_v6_2676_0_1, [Score=70.1, Expect=2e-13]} {RNA1310_29320.1} {RNA815_54680} | |
32. | MligTC455_45496 | 144 | 2.99 | Mlig455_010048 | Neo: - Age: Up-Down-Up Region-enriched R2: 3.720/0.00332 |
CAV2 | 5.162 | 0.770 | 0.746 | 0.856 | 0.938 | 0.857 | 0.995 | Mlig455_010048 {REF} {Length: 2607} {Pfam: Caveolin [PF01146.19, score=125.0]} {Human: ENSG00000105971, CAV2, caveolin 2, [Score=85.5, Expect=3e-21]} {Mouse: ENSMUSG00000000058, Cav2, caveolin 2, [Score=89.4, Expect=7e-23]} {Celegans: WBGene00000301, cav-1, Caveolin-1, [Score=79.0, Expect=2e-18]} {Smed: dd_Smed_v6_8555_0_1, dd_Smed_v6_8555_0_1, [RH, Score=153, Expect=1e-48]} {RNA1509_20287} {RNA1310_50581.1, RNA1509_20287} {RNA1509_20287, RNA815_31873} |
33. | MligTC455_46698 | 2235 | 46.56 | Mlig455_009652 | Neo: - Age: Down-Up-Up Region-enriched R2: 2.372/0.00045 Regeneration-depleted TP: -3.177 |
5.161 | 0.752 | 0.889 | 0.906 | 0.960 | 0.721 | 0.933 | Mlig455_009652 {REF} {Length: 763} {Pfam: WD repeat binding protein EZH2 [PF11616.10, score=33.2]; NOPS (NUC059) domain [PF08075.13, score=29.1]} {RNA1509_45891} {RNA1310_92759} {RNA815_24028} | |
34. | MligTC455_41396 | 187 | 3.9 | Mlig455_012937, Mlig455_031470 | Neo: - Age: - Region-enriched R2: 4.167/0.01146 |
5.141 | 0.741 | 0.807 | 0.853 | 0.927 | 0.829 | 0.984 | Mlig455_012937 {REF} {Length: 1911} {Smed: dd_Smed_v6_11196_0_1, dd_Smed_v6_11196_0_1, [Score=46.6, Expect=1e-06]} {RNA1509_16138} {RNA1310_24329} {RNA815_11818} Mlig455_031470 {REF} {Length: 1745} {Dmel: FBgn0083971, CG34135, [RH, Score=60.1, Expect=1e-10]} {Smed: dd_Smed_v6_11196_0_1, dd_Smed_v6_11196_0_1, [RH, Score=96.3, Expect=3e-23]} {RNA1509_16138} {RNA1310_24329} {RNA815_11818} |
|
35. | MligTC455_52656 | 121 | 2.51 | Mlig455_062381, Mlig455_062408 | Neo: - Age: Down-Up-Down |
5.139 | 0.783 | 0.900 | 0.754 | 0.793 | 0.941 | 0.968 | Mlig455_062381 {REF} {Length: 2245} {RNA1310_26272} {RNA815_22826} Mlig455_062408 {REF} {Length: 2277} {RNA1310_26272} {RNA815_37592} |
|
36. | MligTC455_15586 | 179 | 3.72 | Mlig455_061074 | Neo: - Age: - Region-enriched R2: 6.557/0.00000 |
5.132 | 0.824 | 0.825 | 0.958 | 0.900 | 0.720 | 0.905 | Mlig455_061074 {REF} {Length: 997} {Dmel: FBgn0013467, igl, igloo, [Score=43.5, Expect=3e-06]} {Smed: dd_Smed_v6_4783_0_82, dd_Smed_v6_4783_0_82, [Score=70.1, Expect=6e-16]} {RNA1509_36803} {RNA1310_35463} {RNA815_8499} | |
37. | MligTC455_35773 | 89 | 1.86 | Mlig455_064449, Mlig455_064456 | Neo: - Age: - Region-enriched R2: 5.198/0.00725 |
NANP | 5.123 | 0.896 | 0.936 | 0.995 | 0.833 | 0.721 | 0.742 | Mlig455_064449 {REF} {Length: 503} {NoTransDecoderORF} {RNA1310_53432.2} Mlig455_064456 {REF} {Length: 3122} {Pfam: Haloacid dehalogenase-like hydrolase [PF13419.8, score=56.3]; haloacid dehalogenase-like hydrolase [PF00702.28, score=55.3]; HAD-hyrolase-like [PF13242.8, score=44.6]} {Human: ENSG00000170191, NANP, N-acetylneuraminic acid phosphatase, [RH, Score=47.4, Expect=8e-06]} {Mouse: ENSMUSG00000053916, Nanp, N-acetylneuraminic acid phosphatase, [RH, Score=48.5, Expect=2e-06]} {Celegans: WBGene00018465, F45E1.4, [RH, Score=147, Expect=4e-43]} {Smed: dd_Smed_v6_2813_0_3, dd_Smed_v6_2813_0_3, [Score=174, Expect=2e-50]} {RNA1310_59243} {RNA815_62364} |
38. | MligTC455_19030 | 628 | 13.08 | Mlig455_046052 | Neo: - Age: - Region-enriched R2: 3.353/0.00000 |
ADGRL3 | 5.105 | 0.820 | 0.863 | 0.774 | 0.706 | 0.950 | 0.992 | Mlig455_046052 {REF} {Length: 7405} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=104.9]; 7 transmembrane receptor (Secretin family) [PF00002.26, score=61.8]; GPCR proteolysis site, GPS, motif [PF01825.23, score=54.3]; GPCR-Autoproteolysis INducing (GAIN) domain [PF16489.7, score=28.0]} {Human: ENSG00000150471, ADGRL3, adhesion G protein-coupled receptor L3, [Score=157, Expect=8e-38]} {Mouse: ENSMUSG00000037605, Adgrl3, adhesion G protein-coupled receptor L3, [Score=158, Expect=5e-38]} {Dmel: FBgn0033313, Cirl, Calcium-independent receptor for alpha-latrotoxin, [RH, Score=72.4, Expect=5e-12]} {Celegans: WBGene00002251, lat-1, Latrophilin-like protein 1, [Score=107, Expect=5e-23]} {Smed: dd_Smed_v6_8425_0_1, dd_Smed_v6_8425_0_1, [Score=587, Expect=1e-173]} {RNA1509_17130, RNA1509_4023, RNA1509_47993, RNA1509_50945, RNA1509_52292, RNA1509_52867} {RNA1310_254.2, RNA1509_17130, RNA1509_47993, RNA1509_50945, RNA1509_52292, RNA1509_52867} {RNA1509_17130, RNA1509_47993, RNA1509_50945, RNA1509_52292, RNA1509_52867, RNA815_85.1} |
39. | MligTC455_19338 | 2431 | 50.65 | Mlig455_022165 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.390 Region-specific R2: 3.133 Region-enriched R2: 2.312/0.00036 |
5.081 | 0.714 | 0.868 | 0.787 | 0.952 | 0.835 | 0.925 | Mlig455_022165 {REF} {Length: 1038} {RNA1509_18606, RNA1509_6523} {RNA1310_50737, RNA1509_18606, RNA1509_6523} {RNA1509_18606, RNA1509_6523, RNA815_26880} | |
40. | MligTC455_50927 | 254 | 5.29 | Mlig455_070541, Mlig455_070562 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.296 Region-enriched R2: 7.883/0.00008 |
FZD4 | 5.042 | 0.805 | 0.855 | 0.714 | 0.873 | 0.805 | 0.990 | Mlig455_070541 {REF} {Length: 3522} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=339.1]; Fz domain [PF01392.24, score=88.1]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Dmel: FBgn0001085, fz, frizzled, [Score=315, Expect=3e-98]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=284, Expect=5e-87]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [RH, Score=471, Expect=6e-159]} {RNA1509_15834} {RNA1310_3800, RNA1509_15834} {RNA1509_15834, RNA815_19571} Mlig455_070562 {REF} {Length: 3527} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=339.1]; Fz domain [PF01392.24, score=88.1]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [RH, Score=446, Expect=2e-149]} {Dmel: FBgn0001085, fz, frizzled, [Score=315, Expect=3e-98]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=284, Expect=5e-87]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [RH, Score=470, Expect=8e-159]} {RNA1509_15834} {RNA1310_3800} {RNA815_19571} |
41. | MligTC455_23621 | 323 | 6.72 | Mlig455_039694, Mlig455_039749 | Neo: - Age: - Region-enriched R2: 2.235/0.02499 |
4.986 | 0.726 | 0.749 | 0.835 | 0.734 | 0.947 | 0.995 | Mlig455_039694 {REF} {Length: 2054} {RNA1509_29694} {RNA1310_14789} {RNA815_12997} Mlig455_039749 {REF} {Length: 1751} {RNA1509_29694} {RNA1310_14789, RNA1509_29694} {RNA1509_29694, RNA815_12997} |
|
42. | MligTC455_39957 | 170 | 3.54 | Mlig455_039809 | Neo: - Age: - Region-specific R2: 4.733 Region-enriched R2: 5.232/0.00000 |
ADGB | 4.981 | 0.901 | 0.745 | 0.779 | 0.795 | 0.797 | 0.964 | Mlig455_039809 {REF} {Length: 7010} {tRNA: Ile(TAT),pseudo, score=33.4} {Pfam: Calpain family cysteine protease [PF00648.23, score=34.1]} {Human: ENSG00000118492, ADGB, androglobin, [Score=403, Expect=6e-115]} {Mouse: ENSMUSG00000050994, Adgb, androglobin, [Score=252, Expect=4e-67]} {Celegans: WBGene00000543, clp-2, CaLPain family, [Score=73.2, Expect=1e-12]} {Smed: dd_Smed_v6_10677_0_1, dd_Smed_v6_10677_0_1, [Score=253, Expect=8e-68]} {RNA1509_15950, RNA1509_59203} {RNA1310_4821, RNA1509_59203} {RNA1509_59203, RNA815_12506} |
43. | MligTC455_43963 | 1010 | 21.04 | Mlig455_015437 | Neo: - Age: Down-Down-Up Region-enriched R2: 2.083/0.01168 |
4.975 | 0.709 | 0.771 | 0.897 | 0.863 | 0.757 | 0.978 | Mlig455_015437 {REF} {Length: 612} {RNA1509_32160} {RNA1310_60746, RNA1509_32160} {RNA1509_32160, RNA815_30740} | |
44. | MligTC455_40654 | 676 | 14.08 | Mlig455_056785 | Neo: - Age: logFC(26M/2M)=-0.402 |
CCDC63 | 4.955 | 0.719 | 0.855 | 0.702 | 0.873 | 0.852 | 0.954 | Mlig455_056785 {REF} {Length: 2093} {TRANSSPLICED} {Pfam: Initiation control protein YabA [PF06156.15, score=20.5]} {Human: ENSG00000173093, CCDC63, coiled-coil domain containing 63, [RH, Score=190, Expect=9e-53]} {Mouse: ENSMUSG00000043036, Ccdc63, coiled-coil domain containing 63, [RH, Score=179, Expect=7e-49]} {Dmel: FBgn0038452, CG14905, [RH, Score=168, Expect=6e-46]} {Smed: dd_Smed_v6_4191_0_1, dd_Smed_v6_4191_0_1, [RH, Score=442, Expect=7e-150]} {RNA1509_17628} {RNA1310_12386, RNA1509_17628} {RNA1509_17628, RNA815_7054} |
45. | MligTC455_47807 | 2664 | 55.5 | Mlig455_050143 | Neo: - Age: - Region-specific R2: 3.807 Region-enriched R2: 2.561/0.00001 |
4.907 | 0.730 | 0.891 | 0.712 | 0.983 | 0.712 | 0.879 | Mlig455_050143 {REF} {Length: 1560} {RNA1509_1605, RNA1509_28756} {RNA1310_30659.1, RNA1509_28756} {RNA1509_28756, RNA815_13807} | |
46. | MligTC455_43324 | 71 | 1.47 | Mlig455_041984 | Neo: - Age: - Region-enriched R2: 6.623/0.00573 |
4.822 | 0.707 | 0.901 | 0.726 | 0.744 | 0.771 | 0.973 | Mlig455_041984 {REF} {Length: 388} {NoTransDecoderORF} {RNA1509_49821} {RNA1310_52560.2} {RNA815_59873} | |
47. | MligTC455_45039 | 168 | 3.49 | Mlig455_040482, Mlig455_040487 | Neo: - Age: Down-Up-Down Region-enriched R2: 5.332/0.02336 |
4.774 | - | 0.919 | 0.936 | 0.932 | 0.988 | 0.999 | Mlig455_040482 {REF} {Length: 1774} {RNA1310_20941} {RNA815_45079} Mlig455_040487 {REF} {Length: 5763} {tRNA: Val(CAC),pseudo, score=20.2} {Celegans: WBGene00022195, Y71H2B.5, [Score=146, Expect=8e-36]} {Smed: dd_Smed_v6_16438_0_2, dd_Smed_v6_16438_0_2, [Score=188, Expect=1e-49]} {RNA1509_21228} {RNA1310_20941} {RNA815_45079} |
|
48. | MligTC455_39096 | 110 | 2.29 | Mlig455_019781, Mlig455_019803 | Neo: - Age: - |
4.755 | 0.955 | - | 0.907 | 0.915 | 0.978 | 1.000 | Mlig455_019781 {REF} {Length: 1107} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=65.0]} {RNA1310_34740} {RNA815_15663} Mlig455_019803 {REF} {Length: 1107} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=63.1]} {RNA1310_34740} {RNA815_15663} |
|
49. | MligTC455_41028 | 108 | 2.26 | Mlig455_033278 | Neo: - Age: - |
4.739 | 0.975 | 0.940 | 0.854 | 0.985 | - | 0.985 | Mlig455_033278 {REF} {Length: 1134} {Pfam: PAN domain [PF00024.28, score=19.4]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=68.2, Expect=9e-14]} {RNA1310_31986} {RNA815_17816.2} | |
50. | MligTC455_40352 | 49 | 1.03 | Mlig455_024410 | Neo: - Age: - |
4.727 | 0.964 | - | 0.896 | 0.985 | 0.934 | 0.948 | Mlig455_024410 {REF} {Length: 1509} {TRANSSPLICED} {RNA1310_29008} {RNA815_41596} | |
51. | MligTC455_19266 | 1038 | 21.61 | Mlig455_004528, Mlig455_028530 | Neo: - Age: - Region-specific R2: 2.706 Region-enriched R2: 1.766/0.00005 |
NCALD | 4.727 | - | 0.944 | 0.944 | 0.988 | 0.945 | 0.906 | Mlig455_004528 {REF} {Length: 3958} {tRNA: Val(CAC),pseudo, score=38.6} {Pfam: EF-hand domain pair [PF13499.8, score=74.4]; EF hand [PF00036.34, score=71.3]; EF-hand domain [PF13405.8, score=66.3]; EF hand [PF13202.8, score=62.7]; EF-hand domain pair [PF13833.8, score=50.8]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=22.1]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=19.3]} {Human: ENSG00000104490, NCALD, neurocalcin delta, [Score=194, Expect=4e-63]; ENSG00000115756, HPCAL1, hippocalcin like 1, [Score=191, Expect=1e-61]; ENSG00000121905, HPCA, hippocalcin, [Score=185, Expect=1e-59]} {Mouse: ENSMUSG00000051359, Ncald, neurocalcin delta, [Score=194, Expect=2e-63]; ENSMUSG00000071379, Hpcal1, hippocalcin-like 1, [Score=191, Expect=8e-62]; ENSMUSG00000028785, Hpca, hippocalcin, [Score=185, Expect=1e-59]} {Dmel: FBgn0036926, CG7646, [RH, Score=221, Expect=6e-74]} {Celegans: WBGene00003564, ncs-2, Neuronal calcium sensor 2, [Score=238, Expect=6e-81]} {Smed: dd_Smed_v6_5266_0_1, dd_Smed_v6_5266_0_1, [RH, Score=359, Expect=8e-129]} {RNA1509_14564} {RNA1310_18405, RNA1509_14564} {RNA1509_14564, RNA815_10180.1} Mlig455_028530 {REF} {Length: 3453} {tRNA: Val(CAC),pseudo, score=38.6} {Pfam: EF-hand domain pair [PF13499.8, score=74.4]; EF hand [PF00036.34, score=71.3]; EF-hand domain [PF13405.8, score=66.3]; EF hand [PF13202.8, score=62.7]; EF-hand domain pair [PF13833.8, score=50.8]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=22.1]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=19.3]} {Human: ENSG00000104490, NCALD, neurocalcin delta, [Score=194, Expect=4e-63]; ENSG00000115756, HPCAL1, hippocalcin like 1, [Score=191, Expect=1e-61]; ENSG00000121905, HPCA, hippocalcin, [Score=185, Expect=1e-59]} {Mouse: ENSMUSG00000051359, Ncald, neurocalcin delta, [Score=194, Expect=2e-63]; ENSMUSG00000071379, Hpcal1, hippocalcin-like 1, [Score=191, Expect=8e-62]; ENSMUSG00000028785, Hpca, hippocalcin, [Score=185, Expect=1e-59]} {Dmel: FBgn0036926, CG7646, [RH, Score=221, Expect=6e-74]} {Celegans: WBGene00003564, ncs-2, Neuronal calcium sensor 2, [Score=238, Expect=6e-81]} {Smed: dd_Smed_v6_5266_0_1, dd_Smed_v6_5266_0_1, [RH, Score=359, Expect=8e-129]} {RNA1509_13995, RNA1509_14564, RNA1509_30926} {RNA1310_18405, RNA1509_13995, RNA1509_30926} {RNA1509_13995, RNA1509_30926, RNA815_10180.1} |
52. | MligTC455_51537 | 225 | 4.69 | Mlig455_064569 | Neo: - Age: - |
4.725 | - | 0.894 | 0.978 | 0.990 | 0.925 | 0.938 | Mlig455_064569 {REF} {Length: 2141} {RNA1310_34295.1} {RNA815_22630} | |
53. | MligTC455_42994 | 1521 | 31.7 | Mlig455_035840 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=0.356 Region-enriched R2: 1.854/0.00052 |
4.714 | - | 0.944 | 0.960 | 0.902 | 0.927 | 0.981 | Mlig455_035840 {REF} {Length: 1436} {RNA1509_29485, RNA1509_42231} {RNA1310_26640, RNA1509_29485, RNA1509_42231} {RNA1509_29485, RNA1509_42231, RNA815_37260} | |
54. | MligTC455_19275 | 407 | 8.47 | Mlig455_037548 | Neo: - Age: logFC(26M/2M)=0.488 Region-enriched R2: 3.247/0.04164 |
CHRNA10 | 4.699 | 0.990 | 0.921 | - | 0.990 | 0.942 | 0.856 | Mlig455_037548 {REF} {Length: 959} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=87.9]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=96.7, Expect=1e-22]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=97.1, Expect=7e-23]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=95.1, Expect=5e-22]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=110, Expect=1e-27]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=119, Expect=8e-31]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=93.2, Expect=1e-21]} {RNA1509_23115} {RNA1310_34970} {RNA815_15305.1} |
55. | MligTC455_50355 | 38 | 0.79 | Mlig455_057631 | Neo: - Age: - Region-enriched R2: 7.639/0.01837 |
4.688 | 0.901 | - | 0.930 | 0.881 | 0.979 | 0.997 | Mlig455_057631 {REF} {Length: 1003} {Pfam: WSC domain [PF01822.21, score=45.2]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=47.4, Expect=6e-06]} {RNA1310_44307} {RNA815_33128} | |
56. | MligTC455_42037 | 1931 | 40.23 | Mlig455_063391 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.444 Region-specific R2: 2.479 Region-enriched R2: 1.442/0.00136 |
4.68 | - | 0.875 | 0.955 | 0.942 | 0.948 | 0.960 | Mlig455_063391 {REF} {Length: 1482} {RNA1509_22218, RNA1509_26529, RNA1509_28020, RNA1509_35236} {RNA1310_24553, RNA1509_22218, RNA1509_26529, RNA1509_28020, RNA1509_35236} {RNA1509_22218, RNA1509_26529, RNA1509_28020, RNA1509_35236, RNA815_11766} | |
57. | MligTC455_48022 | 1337 | 27.86 | Mlig455_045267, Mlig455_069186 | Neo: - Age: - Region-enriched R2: 2.130/0.00146 |
4.673 | - | 0.929 | 0.986 | 0.962 | 0.899 | 0.897 | Mlig455_045267 {REF} {Length: 3628} {Pfam: Ankyrin repeats (many copies) [PF13857.8, score=29.5]; Ankyrin repeats (many copies) [PF13637.8, score=28.4]; Ankyrin repeats (3 copies) [PF12796.9, score=28.3]; Ankyrin repeat [PF13606.8, score=23.5]} {Celegans: WBGene00009375, F34D10.6, [Score=57.0, Expect=6e-08]} {Smed: dd_Smed_v6_5594_0_3, dd_Smed_v6_5594_0_3, [Score=58.5, Expect=1e-08]} {RNA1509_17412, RNA1509_32079} {RNA1310_5952, RNA1509_17412, RNA1509_32079} {RNA1509_17412, RNA1509_32079, RNA815_2323} Mlig455_069186 {REF} {Length: 3598} {Pfam: Ankyrin repeats (many copies) [PF13637.8, score=30.4]; Ankyrin repeats (3 copies) [PF12796.9, score=30.1]; Ankyrin repeats (many copies) [PF13857.8, score=29.5]; Ankyrin repeat [PF13606.8, score=24.1]} {Celegans: WBGene00009375, F34D10.6, [Score=56.6, Expect=6e-08]} {Smed: dd_Smed_v6_5594_0_4, dd_Smed_v6_5594_0_4, [Score=59.3, Expect=7e-09]} {RNA1509_52963} {RNA1310_5952, RNA1509_52963} {RNA1509_52963, RNA815_2323} |
|
58. | MligTC455_32312 | 65 | 1.36 | Mlig455_026936, Mlig455_027086 | Neo: - Age: Up-Down-Down Region-enriched R2: 9.552/0.00000 |
4.658 | 0.998 | 0.921 | 0.997 | - | 0.901 | 0.841 | Mlig455_026936 {REF} {Length: 1813} {Pfam: PAN domain [PF00024.28, score=22.0]} {RNA1310_30037.2} {RNA815_37290} Mlig455_027086 {REF} {Length: 7697} {Pfam: PAN domain [PF00024.28, score=21.9]} {RNA1509_4722} {RNA1310_655.1} {RNA815_786} |
|
59. | MligTC455_35258 | 2779 | 57.89 | Mlig455_040964 | Neo: - Age: Up-Down-Down Region-specific R2: 2.469 Region-enriched R2: 1.501/0.00133 |
4.658 | - | 0.770 | 0.965 | 0.983 | 0.953 | 0.987 | Mlig455_040964 {REF} {Length: 8259} {Smed: dd_Smed_v6_8425_0_1, dd_Smed_v6_8425_0_1, [Score=543, Expect=9e-160]} {RNA1509_16633, RNA1509_52679} {RNA1310_236.2, RNA1509_16633} {RNA1509_16633, RNA815_77.1} | |
60. | MligTC455_27650 | 178 | 3.72 | Mlig455_017720 | Neo: - Age: logFC(26M/2M)=-0.928 Region-enriched R2: 3.586/0.00082 |
ADAM33 | 4.649 | 0.914 | 0.902 | 0.928 | - | 0.956 | 0.949 | Mlig455_017720 {REF} {Length: 4499} {Pfam: Reprolysin (M12B) family zinc metalloprotease [PF01421.21, score=124.3]; Disintegrin [PF00200.25, score=66.8]; Metallo-peptidase family M12 [PF13688.8, score=62.2]; ADAM cysteine-rich [PF08516.14, score=61.3]; Metallo-peptidase family M12B Reprolysin-like [PF13582.8, score=33.1]} {Human: ENSG00000149451, ADAM33, ADAM metallopeptidase domain 33, [Score=237, Expect=1e-64]; ENSG00000151651, ADAM8, ADAM metallopeptidase domain 8, [Score=233, Expect=2e-63]; ENSG00000168615, ADAM9, ADAM metallopeptidase domain 9, [Score=230, Expect=2e-62]; ENSG00000148848, ADAM12, ADAM metallopeptidase domain 12, [Score=228, Expect=4e-61]; ENSG00000069206, ADAM7, ADAM metallopeptidase domain 7, [Score=226, Expect=4e-61]; ENSG00000042980, ADAM28, ADAM metallopeptidase domain 28, [Score=226, Expect=4e-61]} {Mouse: ENSMUSG00000079058, Adam34, a disintegrin and metallopeptidase domain 34, [RH, Score=248, Expect=4e-69]; ENSMUSG00000050190, Gm5346, predicted gene 5346, [RH, Score=239, Expect=3e-66]} {Dmel: FBgn0265140, Meltrin, [RH, Score=288, Expect=1e-79]} {Celegans: WBGene00000074, adm-2, ADAM (Disintegrin plus metalloprotease) family, [Score=246, Expect=3e-67]} {Smed: dd_Smed_v6_5143_0_1, dd_Smed_v6_5143_0_1, [Score=225, Expect=3e-60]} {RNA1509_7654} {RNA1310_9319.1} {RNA815_4173.1} |
61. | MligTC455_41540 | 190 | 3.96 | Mlig455_060056 | Neo: - Age: - Region-enriched R2: 6.605/0.00196 |
GLUL | 4.637 | - | 0.793 | 0.927 | 0.934 | 0.983 | 1.000 | Mlig455_060056 {REF} {Length: 1355} {Pfam: Glutamine synthetase, catalytic domain [PF00120.26, score=57.3]; Glutamine synthetase, beta-Grasp domain [PF03951.21, score=47.5]} {Human: ENSG00000135821, GLUL, glutamate-ammonia ligase, [RH, Score=511, Expect=1e-180]} {Mouse: ENSMUSG00000026473, Glul, glutamate-ammonia ligase (glutamine synthetase), [RH, Score=511, Expect=0.0]} {Dmel: FBgn0001145, Gs2, Glutamine synthetase 2, [RH, Score=511, Expect=0.0]} {Celegans: WBGene00001604, gln-3, Glutamine synthetase, [RH, Score=515, Expect=0.0]} {Smed: dd_Smed_v6_896_0_1, dd_Smed_v6_896_0_1, [RH, Score=545, Expect=0.0]} {RNA1509_47000} {RNA1310_22329.2} {RNA815_4116.6} |
62. | MligTC455_18506 | 59 | 1.23 | Mlig455_038054 | Neo: - Age: Down-Up-Down |
SP9 | 4.626 | - | 0.782 | 0.995 | 0.933 | 0.921 | 0.995 | Mlig455_038054 {REF} {Length: 3168} {Pfam: Zinc-finger double domain [PF13465.8, score=49.0]; Zinc finger, C2H2 type [PF00096.28, score=40.9]; C2H2-type zinc finger [PF13894.8, score=26.8]} {Human: ENSG00000217236, SP9, Sp9 transcription factor, [RH, Score=202, Expect=4e-59]; ENSG00000164651, SP8, Sp8 transcription factor, [RH, Score=202, Expect=5e-59]} {Mouse: ENSMUSG00000068859, Sp9, trans-acting transcription factor 9, [RH, Score=202, Expect=3e-59]; ENSMUSG00000048562, Sp8, trans-acting transcription factor 8, [RH, Score=201, Expect=9e-59]} {Dmel: FBgn0020378, Sp1, [RH, Score=198, Expect=6e-56]} {Celegans: WBGene00012735, sptf-3, SP (Specificity Protein) Transcription Factor, [Score=137, Expect=1e-35]} {Smed: dd_Smed_v6_17385_0_1, dd_Smed_v6_17385_0_1, [RH, Score=160, Expect=5e-46]} {RNA1310_42373} |
63. | MligTC455_38368 | 107 | 2.24 | Mlig455_026435, Mlig455_044757 | Neo: - Age: Up-Down-Down |
SSUH2 | 4.624 | - | 0.922 | 0.977 | 0.881 | 0.936 | 0.908 | Mlig455_026435 {REF} {Length: 1789} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [RH, Score=233, Expect=1e-72]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [RH, Score=195, Expect=1e-58]} {Celegans: WBGene00013455, ssu-2, Suppressor of Stomatin mutant Uncoordination, [Score=117, Expect=3e-29]} {RNA1509_6425} {RNA1310_32434} {RNA815_16161} Mlig455_044757 {REF} {Length: 883} {TRANSSPLICED} {RNA1509_28356} {RNA1310_61125} {RNA815_53103} |
64. | MligTC455_40851 | 132 | 2.76 | Mlig455_042077 | Neo: - Age: logFC(26M/2M)=0.724 Region-enriched R2: 3.969/0.02676 |
PKD1L2 | 4.613 | 0.987 | 0.805 | - | 0.937 | 0.914 | 0.970 | Mlig455_042077 {REF} {Length: 4836} {Pfam: PLAT/LH2 domain [PF01477.25, score=68.6]; Polycystin cation channel [PF08016.14, score=53.9]} {Human: ENSG00000166473, PKD1L2, polycystin 1 like 2 (gene/pseudogene), [Score=220, Expect=3e-58]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=212, Expect=7e-56]} {Dmel: FBgn0050048, CG30048, [Score=55.8, Expect=2e-07]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=122, Expect=1e-27]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=328, Expect=2e-94]} {RNA1509_8046} {RNA1310_93} {RNA815_1216} |
65. | MligTC455_53546 | 130 | 2.72 | Mlig455_013326, Mlig455_013334 | Neo: - Age: - Region-enriched R2: 6.753/0.01892 |
MMP9 | 4.606 | 0.984 | 0.885 | 0.931 | 0.826 | - | 0.980 | Mlig455_013326 {REF} {Length: 1449} {Pfam: Fibronectin type II domain [PF00040.21, score=92.5]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=87.8, Expect=3e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=82.4, Expect=1e-16]; ENSMUSG00000031740, Mmp2, matrix metallopeptidase 2, [RH, Score=78.6, Expect=2e-15]} {Smed: dd_Smed_v6_14558_0_1, dd_Smed_v6_14558_0_1, [RH, Score=138, Expect=3e-38]} {RNA1310_38631} {RNA815_51136} Mlig455_013334 {REF} {Length: 1398} {Pfam: Fibronectin type II domain [PF00040.21, score=92.1]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=89.4, Expect=1e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=84.0, Expect=4e-17]} {Smed: dd_Smed_v6_12601_0_1, dd_Smed_v6_12601_0_1, [RH, Score=140, Expect=2e-38]} {RNA1310_38631} {RNA815_51136} |
66. | MligTC455_26652 | 30 | 0.63 | Mlig455_036452 | Neo: - Age: - |
NR2E1 | 4.594 | 0.902 | 0.792 | 0.971 | 0.993 | - | 0.936 | Mlig455_036452 {REF} {Length: 2848} {Pfam: Zinc finger, C4 type (two domains) [PF00105.20, score=99.9]; Ligand-binding domain of nuclear hormone receptor [PF00104.32, score=55.3]} {Human: ENSG00000112333, NR2E1, nuclear receptor subfamily 2 group E member 1, [Score=139, Expect=2e-35]} {Mouse: ENSMUSG00000019803, Nr2e1, nuclear receptor subfamily 2, group E, member 1, [Score=139, Expect=1e-35]} {Dmel: FBgn0015381, dsf, dissatisfaction, [Score=129, Expect=6e-31]} {Celegans: WBGene00021417, nhr-236, Nuclear Hormone Receptor family, [RH, Score=135, Expect=1e-35]} {Smed: dd_Smed_v6_25420_0_1, dd_Smed_v6_25420_0_1, [RH, Score=182, Expect=3e-50]} {RNA1310_57853} {RNA815_57699} |
67. | MligTC455_29914 | 44 | 0.91 | Mlig455_027923 | Neo: - Age: Down-Up-Down Region-enriched R2: 8.096/0.00455 |
ANGPTL3 | 4.594 | 0.893 | - | 0.980 | 0.893 | 0.854 | 0.974 | Mlig455_027923 {REF} {Length: 1663} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=70.5]} {Human: ENSG00000132855, ANGPTL3, angiopoietin like 3, [Score=60.5, Expect=9e-10]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=59.3, Expect=2e-09]; ENSG00000120332, TNN, tenascin N, [Score=58.9, Expect=3e-09]} {Mouse: ENSMUSG00000015829, Tnr, tenascin R, [Score=62.4, Expect=2e-10]} {Dmel: FBgn0031804, CG9500, [Score=76.3, Expect=6e-16]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=51.2, Expect=3e-07]} {RNA1509_53291} {RNA1310_58974} {RNA815_43288.3} |
68. | MligTC455_40714 | 93 | 1.94 | Mlig455_008848 | Neo: - Age: - Region-enriched R2: 5.100/0.02617 |
4.589 | 0.977 | 0.898 | 0.773 | 0.942 | - | 0.999 | Mlig455_008848 {REF} {Length: 2258} {RNA1310_21537} {RNA815_13165} | |
69. | MligTC455_17464 | 409 | 8.52 | Mlig455_048989, Mlig455_049006, Mlig455_067762 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.512 Regeneration-downregulated BL: -7.800 Regeneration-depleted BL: -7.800 |
4.583 | - | 0.835 | 0.945 | 0.833 | 0.976 | 0.994 | Mlig455_048989 {REF} {Length: 1272} {RNA1310_37715} {RNA815_39767} Mlig455_049006 {REF} {Length: 1028} {RNA1310_37715} {RNA815_39767} Mlig455_067762 {REF} {Length: 1353} {RNA1310_37715} {RNA815_39767} |
|
70. | MligTC455_46394 | 8810 | 183.54 | Mlig455_054818, Mlig455_054826 | Neo: - Age: - Region-specific R2: 1.771 Region-enriched R2: 1.255/0.00038 |
PKD2 | 4.573 | - | 0.885 | 0.847 | 0.964 | 0.896 | 0.981 | Mlig455_054818 {REF} {Length: 2992} {TRANSSPLICED} {Pfam: Polycystin cation channel [PF08016.14, score=487.7]; Ion transport protein [PF00520.33, score=93.3]; EF hand [PF00036.34, score=32.7]; Ferredoxin I 4Fe-4S cluster domain [PF18109.3, score=21.3]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=750, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=747, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=323, Expect=1e-96]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=380, Expect=6e-120]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [Score=733, Expect=0.0]} {RNA1509_1615} {RNA1310_21296.2, RNA1509_1615} {RNA1509_1615, RNA815_3158.1} Mlig455_054826 {REF} {Length: 3118} {TRANSSPLICED} {Pfam: Polycystin cation channel [PF08016.14, score=487.7]; Ion transport protein [PF00520.33, score=93.4]; EF hand [PF00036.34, score=32.6]; Ferredoxin I 4Fe-4S cluster domain [PF18109.3, score=21.2]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=754, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=751, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=323, Expect=2e-96]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=387, Expect=1e-122]} {Smed: dd_Smed_v6_13327_0_1, dd_Smed_v6_13327_0_1, [RH, Score=769, Expect=0.0]} {RNA1509_13522} {RNA1310_21296.2} {RNA815_3158.1} |
71. | MligTC455_16908 | 161 | 3.35 | Mlig455_046916 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.397 Region-enriched R2: 2.938/0.02849 |
SLC17A6 | 4.57 | 0.957 | 0.851 | - | 0.870 | 0.930 | 0.962 | Mlig455_046916 {REF} {Length: 3198} {Pfam: Major Facilitator Superfamily [PF07690.18, score=172.0]; Uncharacterised MFS-type transporter YbfB [PF06779.16, score=19.6]} {Human: ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [RH, Score=548, Expect=0.0]; ENSG00000179520, SLC17A8, solute carrier family 17 member 8, [RH, Score=542, Expect=0.0]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [RH, Score=536, Expect=0.0]} {Mouse: ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [RH, Score=551, Expect=0.0]; ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [RH, Score=547, Expect=0.0]; ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [RH, Score=543, Expect=0.0]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=482, Expect=6e-163]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [RH, Score=479, Expect=7e-163]} {Smed: dd_Smed_v6_10192_0_1, dd_Smed_v6_10192_0_1, [RH, Score=591, Expect=0.0]} {RNA1509_38152} {RNA1310_23072, RNA1509_38152} {RNA1509_38152, RNA815_14894} |
72. | MligTC455_19875 | 82 | 1.71 | Mlig455_024408 | Neo: - Age: Down-Up-Down |
4.569 | 0.852 | 0.961 | 0.886 | 0.928 | - | 0.942 | Mlig455_024408 {REF} {Length: 2479} {Pfam: CD20-like family [PF04103.17, score=40.9]} {Mouse: ENSMUSG00000048004, Tmem196, transmembrane protein 196, [Score=63.5, Expect=2e-12]} {Smed: dd_Smed_v6_14043_0_1, dd_Smed_v6_14043_0_1, [Score=184, Expect=5e-59]} {RNA1509_25506} {RNA1310_4968.1} {RNA815_23744} | |
73. | MligTC455_13130 | 40 | 0.83 | Mlig455_032511, Mlig455_068691 | Neo: - Age: - |
WSCD2 | 4.567 | - | 0.798 | 0.993 | 0.961 | 0.849 | 0.966 | Mlig455_032511 {REF} {Length: 927} {Pfam: WSC domain [PF01822.21, score=40.9]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=50.4, Expect=6e-07]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=50.4, Expect=4e-07]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=60.1, Expect=2e-10]} {RNA1310_39527} {RNA815_19067} Mlig455_068691 {REF} {Length: 927} {Pfam: WSC domain [PF01822.21, score=41.8]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=50.1, Expect=1e-06]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=49.7, Expect=9e-07]; ENSMUSG00000020393, Kremen1, kringle containing transmembrane protein 1, [Score=47.8, Expect=4e-06]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=62.0, Expect=6e-11]} {RNA1310_39527} {RNA815_19067} |
74. | MligTC455_19279 | 4576 | 95.33 | Mlig455_057411 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.654 Region-specific R2: 5.173 Region-enriched R2: 4.585/0.00000 |
CHRNA10 | 4.564 | - | 0.958 | 0.850 | 0.955 | 0.858 | 0.943 | Mlig455_057411 {REF} {Length: 1075} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=85.3]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=91.3, Expect=1e-20]} {Mouse: ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=92.0, Expect=7e-21]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=88.2, Expect=1e-19]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=110, Expect=2e-27]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=120, Expect=4e-31]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=96.3, Expect=8e-23]} {RNA1509_1306} {RNA1310_34970} {RNA815_15305.1} |
75. | MligTC455_45019 | 64 | 1.33 | Mlig455_009383, Mlig455_036937 | Neo: - Age: - |
WSCD2 | 4.564 | - | 0.815 | 0.938 | 0.984 | 0.914 | 0.913 | Mlig455_009383 {REF} {Length: 854} {Pfam: WSC domain [PF01822.21, score=58.2]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=59.7, Expect=6e-10]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=60.5, Expect=2e-10]} {RNA1310_43246} {RNA815_43085} Mlig455_036937 {REF} {Length: 858} {Pfam: WSC domain [PF01822.21, score=58.2]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=59.7, Expect=6e-10]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=60.5, Expect=2e-10]} {RNA1310_43246} {RNA815_43085} |
76. | MligTC455_46708 | 362 | 7.53 | Mlig455_045334 | Neo: - Age: - Region-enriched R2: 2.783/0.01800 |
4.56 | - | 0.912 | 0.935 | 0.814 | 0.935 | 0.964 | Mlig455_045334 {REF} {Length: 1243} {RNA1509_51601} {RNA1310_43115.2, RNA1509_51601} {RNA1509_51601, RNA815_21402.1} | |
77. | MligTC455_54282 | 74 | 1.54 | Mlig455_020191 | Neo: - Age: - |
4.552 | 0.886 | - | 0.965 | 0.979 | 0.729 | 0.993 | Mlig455_020191 {REF} {Length: 937} {RNA1509_48973} {RNA1310_40738.2} {RNA815_31898} | |
78. | MligTC455_18683 | 419 | 8.74 | Mlig455_069928 | Neo: - Age: - Region-specific R2: 6.066 Region-enriched R2: 4.921/0.00217 |
4.548 | - | 0.831 | 0.900 | 0.837 | 0.980 | 1.000 | Mlig455_069928 {REF} {Length: 845} {RNA1509_25826} {RNA1310_42757} {RNA815_23874} | |
79. | MligTC455_18682 | 1190 | 24.79 | Mlig455_037756 | Neo: - Age: Up-Down-Down Region-specific R2: 4.877 Region-enriched R2: 4.609/0.00000 |
4.547 | - | 0.826 | 0.897 | 0.842 | 0.982 | 1.000 | Mlig455_037756 {REF} {Length: 1188} {RNA1509_25826} {RNA1310_42757} {RNA815_23874} | |
80. | MligTC455_44328 | 858 | 17.88 | Mlig455_026172 | Neo: - Age: Down-Up-Up Region-specific R2: 4.714 Region-enriched R2: 4.385/0.00000 |
4.542 | 0.903 | 0.958 | 0.912 | 0.814 | - | 0.955 | Mlig455_026172 {REF} {Length: 661} {RNA1509_32102, RNA1509_34635} {RNA1310_60068, RNA1509_32102, RNA1509_34635} {RNA1509_32102, RNA1509_34635, RNA815_37486} | |
81. | MligTC455_40961 | 1390 | 28.96 | Mlig455_055735 | Neo: - Age: Down-Up-Up Region-specific R2: 4.023 Region-enriched R2: 3.902/0.00000 |
4.537 | 0.968 | 0.950 | 0.890 | 0.796 | - | 0.933 | Mlig455_055735 {REF} {Length: 782} {Pfam: Pancreatic hormone peptide [PF00159.20, score=36.6]} {RNA1509_12482, RNA1509_45015, RNA1509_52082} {RNA1310_48462, RNA1509_12482, RNA1509_45015, RNA1509_52082} {RNA1509_12482, RNA1509_45015, RNA1509_52082, RNA815_25160} | |
82. | MligTC455_44713 | 661 | 13.77 | Mlig455_048154 | Neo: - Age: logFC(26M/2M)=0.569 Region-specific R2: 3.883 Region-enriched R2: 3.422/0.00000 |
4.536 | 0.848 | 0.978 | 0.896 | 0.859 | - | 0.955 | Mlig455_048154 {REF} {Length: 1173} {RNA1509_34252} {RNA1310_54269.1} {RNA815_55074} | |
83. | MligTC455_53682 | 393 | 8.18 | Mlig455_064952, Mlig455_066834 | Neo: - Age: Down-Up-Up Region-specific R2: 5.926 Region-enriched R2: 4.442/0.00896 |
4.527 | - | 0.884 | 0.897 | 0.867 | 0.904 | 0.975 | Mlig455_064952 {REF} {Length: 1573} {Pfam: PAN domain [PF00024.28, score=20.0]} {RNA1310_33258} {RNA815_17150} Mlig455_066834 {REF} {Length: 1573} {Pfam: PAN domain [PF00024.28, score=20.0]} {RNA1310_33258} {RNA815_17150} |
|
84. | MligTC455_20091 | 41 | 0.85 | Mlig455_053591 | Neo: - Age: - |
TNN | 4.525 | - | 0.772 | 0.846 | 0.982 | 0.974 | 0.951 | Mlig455_053591 {REF} {Length: 1556} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=132.6]; PAN domain [PF00024.28, score=21.9]} {Human: ENSG00000120332, TNN, tenascin N, [Score=105, Expect=8e-25]} {Mouse: ENSMUSG00000026725, Tnn, tenascin N, [Score=102, Expect=9e-24]; ENSMUSG00000026835, Fcnb, ficolin B, [Score=99.4, Expect=7e-24]; ENSMUSG00000026938, Fcna, ficolin A, [Score=97.8, Expect=4e-23]} {Dmel: FBgn0050280, CG30280, [Score=108, Expect=1e-27]} {Celegans: WBGene00016769, C49C8.5, [Score=46.2, Expect=1e-05]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=112, Expect=6e-28]} {RNA1310_44715} {RNA815_35355} |
85. | MligTC455_50567 | 146 | 3.04 | Mlig455_012858 | Neo: - Age: - Region-specific R2: 6.162 Region-enriched R2: 5.988/0.01054 |
4.515 | - | 0.873 | 0.939 | 0.998 | 0.907 | 0.798 | Mlig455_012858 {REF} {Length: 1282} {Pfam: F5/8 type C domain [PF00754.27, score=27.5]} {Smed: dd_Smed_v6_36585_0_1, dd_Smed_v6_36585_0_1, [RH, Score=64.3, Expect=4e-12]} {RNA1310_34633} {RNA815_12537} | |
86. | MligTC455_33832 | 112 | 2.34 | Mlig455_029411 | Neo: - Age: Up-Down-Down Region-enriched R2: 5.300/0.00016 |
GLRA3 | 4.507 | 0.854 | - | 0.905 | 0.994 | 0.831 | 0.923 | Mlig455_029411 {REF} {Length: 3686} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=149.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=84.5]} {Human: ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=257, Expect=5e-80]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=253, Expect=3e-78]; ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=250, Expect=4e-77]} {Mouse: ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=251, Expect=2e-77]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=249, Expect=5e-77]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=248, Expect=2e-76]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=243, Expect=1e-74]} {Dmel: FBgn0024963, GluClalpha, [Score=253, Expect=2e-78]} {Celegans: WBGene00000233, avr-15, GluClalpha2B protein, [Score=259, Expect=7e-81]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [RH, Score=480, Expect=1e-167]} {RNA1509_35986} {RNA1310_35528} {RNA815_35433} |
87. | MligTC455_40610 | 165 | 3.43 | Mlig455_064484 | Neo: - Age: - Region-enriched R2: 5.617/0.00105 |
4.505 | - | 0.863 | 0.963 | 0.860 | 0.819 | 1.000 | Mlig455_064484 {REF} {Length: 2931} {Pfam: Sushi repeat (SCR repeat) [PF00084.22, score=24.9]} {Smed: dd_Smed_v6_41498_0_1, dd_Smed_v6_41498_0_1, [Score=154, Expect=2e-40]} {RNA1509_26568} {RNA1310_9342.1, RNA1509_26568} {RNA1509_26568, RNA815_7018} | |
88. | MligTC455_19042 | 3679 | 76.64 | Mlig455_030661 | Neo: - Age: logFC(26M/2M)=0.480 Region-specific R2: 2.811 Region-enriched R2: 1.755/0.00003 |
CAV1 | 4.504 | - | 0.837 | 0.909 | 0.824 | 0.984 | 0.950 | Mlig455_030661 {REF} {Length: 1257} {Pfam: Caveolin [PF01146.19, score=124.8]} {Human: ENSG00000105974, CAV1, caveolin 1, [Score=105, Expect=2e-29]} {Mouse: ENSMUSG00000007655, Cav1, caveolin 1, caveolae protein, [Score=105, Expect=2e-29]} {Celegans: WBGene00000301, cav-1, Caveolin-1, [RH, Score=81.6, Expect=8e-20]} {Smed: dd_Smed_v6_13481_0_1, dd_Smed_v6_13481_0_1, [RH, Score=144, Expect=1e-45]} {RNA1509_52150, RNA1509_53381, RNA1509_6093, RNA1509_8522} {RNA1310_31540, RNA1509_52150, RNA1509_53381, RNA1509_6093, RNA1509_8522} {RNA1509_52150, RNA1509_53381, RNA1509_6093, RNA1509_8522, RNA815_14585} |
89. | MligTC455_41130 | 1186 | 24.72 | Mlig455_000166, Mlig455_000179, Mlig455_067712 | Neo: - Age: Down-Up-Down Region-specific R2: 5.626 Region-enriched R2: 4.906/0.00009 Regeneration-downregulated R3: -5.200 Regeneration-depleted R3: -5.200 |
4.503 | 0.703 | 0.901 | 0.930 | 0.969 | - | 1.000 | Mlig455_000166 {REF} {Length: 479} {RNA1509_36590} {RNA1310_65705} Mlig455_000179 {REF} {Length: 479} {RNA1509_36590} {RNA1310_65705} Mlig455_067712 {REF} {Length: 479} {RNA1509_36590} {RNA1310_65705} |
|
90. | MligTC455_26766 | 638 | 13.3 | Mlig455_017977 | Neo: - Age: Up-Down-Down Region-specific R2: 4.360 Region-enriched R2: 3.395/0.00052 |
4.499 | - | 0.920 | 0.988 | 0.729 | 0.867 | 0.995 | Mlig455_017977 {REF} {Length: 2516} {Smed: dd_Smed_v6_10627_0_1, dd_Smed_v6_10627_0_1, [Score=249, Expect=3e-71]} {RNA1509_19813} {RNA1310_621} {RNA815_183.1} | |
91. | MligTC455_52120 | 179 | 3.73 | Mlig455_024423, Mlig455_024577 | Neo: - Age: Down-Up-Down Region-enriched R2: 4.068/0.01755 |
POU4F3 | 4.495 | 0.910 | 0.849 | 0.919 | - | 0.854 | 0.963 | Mlig455_024423 {REF} {Length: 1288} {TRANSSPLICED} {Pfam: Pou domain - N-terminal to homeobox domain [PF00157.19, score=104.8]; Homeodomain [PF00046.31, score=60.9]} {Human: ENSG00000091010, POU4F3, POU class 4 homeobox 3, [Score=212, Expect=1e-65]; ENSG00000152192, POU4F1, POU class 4 homeobox 1, [Score=211, Expect=2e-64]} {Mouse: ENSMUSG00000024497, Pou4f3, POU domain, class 4, transcription factor 3, [Score=212, Expect=7e-66]; ENSMUSG00000048349, Pou4f1, POU domain, class 4, transcription factor 1, [Score=211, Expect=2e-64]} {Dmel: FBgn0000028, acj6, abnormal chemosensory jump 6, [Score=209, Expect=2e-64]} {Celegans: WBGene00006818, unc-86, Transcription factor unc-86, [Score=188, Expect=4e-57]} {Smed: dd_Smed_v6_30562_0_1, dd_Smed_v6_30562_0_1, [Score=208, Expect=2e-64]} {RNA1509_57422} {RNA1310_23131} {RNA815_34447} Mlig455_024577 {REF} {Length: 1325} {TRANSSPLICED} {Pfam: Pou domain - N-terminal to homeobox domain [PF00157.19, score=104.8]; Homeodomain [PF00046.31, score=60.9]} {Human: ENSG00000091010, POU4F3, POU class 4 homeobox 3, [Score=212, Expect=1e-65]; ENSG00000152192, POU4F1, POU class 4 homeobox 1, [Score=211, Expect=2e-64]} {Mouse: ENSMUSG00000024497, Pou4f3, POU domain, class 4, transcription factor 3, [Score=212, Expect=7e-66]; ENSMUSG00000048349, Pou4f1, POU domain, class 4, transcription factor 1, [Score=211, Expect=2e-64]} {Dmel: FBgn0000028, acj6, abnormal chemosensory jump 6, [Score=209, Expect=2e-64]} {Celegans: WBGene00006818, unc-86, Transcription factor unc-86, [Score=188, Expect=4e-57]} {Smed: dd_Smed_v6_30562_0_1, dd_Smed_v6_30562_0_1, [Score=208, Expect=2e-64]} {RNA1509_57422} {RNA1310_23131} {RNA815_34447} |
92. | MligTC455_40289 | 93 | 1.94 | Mlig455_017727, Mlig455_056175 | Neo: - Age: - |
BMP1, CUBN | 4.492 | 0.820 | - | 0.978 | 0.953 | 0.795 | 0.946 | Mlig455_017727 {REF} {Length: 1202} {Pfam: CUB domain [PF00431.22, score=55.3]} {Human: ENSG00000107611, CUBN, cubilin, [Score=54.7, Expect=4e-08]; ENSG00000168487, BMP1, bone morphogenetic protein 1, [Score=52.0, Expect=3e-07]} {Mouse: ENSMUSG00000026726, Cubn, cubilin (intrinsic factor-cobalamin receptor), [Score=51.6, Expect=3e-07]; ENSMUSG00000022098, Bmp1, bone morphogenetic protein 1, [Score=49.7, Expect=1e-06]} {Dmel: FBgn0003719, tld, tolloid, [Score=51.2, Expect=3e-07]} {Smed: dd_Smed_v6_69474_0_1, dd_Smed_v6_69474_0_1, [Score=47.4, Expect=2e-07]} {RNA1310_48745} {RNA815_23305} Mlig455_056175 {REF} {Length: 2747} {Pfam: CUB domain [PF00431.22, score=62.6]} {Human: ENSG00000168487, BMP1, bone morphogenetic protein 1, [Score=52.8, Expect=2e-07]; ENSG00000107611, CUBN, cubilin, [Score=51.6, Expect=4e-07]} {Mouse: ENSMUSG00000022098, Bmp1, bone morphogenetic protein 1, [Score=51.6, Expect=3e-07]; ENSMUSG00000026726, Cubn, cubilin (intrinsic factor-cobalamin receptor), [Score=49.7, Expect=1e-06]} {Dmel: FBgn0003719, tld, tolloid, [Score=51.2, Expect=3e-07]} {Smed: dd_Smed_v6_69474_0_1, dd_Smed_v6_69474_0_1, [Score=47.0, Expect=3e-07]} {RNA1310_48745} {RNA815_23305} |
93. | MligTC455_50532 | 259 | 5.4 | Mlig455_019987 | Neo: - Age: Down-Up-Down |
NEFH | 4.489 | 0.821 | 0.854 | - | 0.972 | 0.857 | 0.985 | Mlig455_019987 {REF} {Length: 4055} {Human: ENSG00000100285, NEFH, neurofilament heavy, [Score=65.5, Expect=3e-10]} {RNA1509_41200, RNA1509_57173} {RNA1310_3614.2, RNA1509_41200, RNA1509_57173} {RNA1509_41200, RNA1509_57173, RNA815_5328} |
94. | MligTC455_14904 | 4225 | 88.01 | Mlig455_037596 | Neo: - Age: logFC(26M/2M)=0.385 Region-enriched R8: 1.541/0.00053 |
4.486 | - | 0.853 | 0.879 | 0.850 | 0.935 | 0.969 | Mlig455_037596 {REF} {Length: 2914} {Dmel: FBgn0034294, Muc55B, Mucin 55B, [Score=59.3, Expect=3e-09]} {RNA1509_17730, RNA1509_4337} {RNA1310_7259, RNA1509_17730} {RNA1509_17730, RNA815_206} | |
95. | MligTC455_49824 | 466 | 9.71 | Mlig455_036536 | Neo: - Age: - Region-specific R2: 4.841 Region-enriched R2: 3.862/0.00010 |
4.483 | 0.804 | 0.967 | 0.883 | 0.841 | - | 0.988 | Mlig455_036536 {REF} {Length: 1139} {Pfam: Nucleoporin FG repeat region [PF13634.8, score=21.2]} {Celegans: WBGene00003748, nlp-10, Neuropeptide-Like Protein, [RH, Score=49.3, Expect=7e-08]} {RNA1509_18714, RNA1509_59524} {RNA1310_41906, RNA1509_18714, RNA1509_59524} {RNA1509_18714, RNA1509_59524, RNA815_24488} | |
96. | MligTC455_46430 | 62 | 1.29 | Mlig455_057117, Mlig455_069301 | Neo: - Age: - |
GUCY2F | 4.462 | 0.892 | 0.826 | 0.940 | 0.808 | - | 0.996 | Mlig455_057117 {REF} {Length: 2651} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=196.0]; Nitrate and nitrite sensing [PF08376.12, score=82.5]; Heme NO binding associated [PF07701.16, score=28.2]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=247, Expect=9e-70]; ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=242, Expect=3e-68]; ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=238, Expect=5e-67]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [Score=246, Expect=7e-70]; ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=242, Expect=2e-68]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=241, Expect=7e-68]; ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=239, Expect=3e-67]} {Dmel: FBgn0053958, CG33958, [Score=266, Expect=4e-79]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=235, Expect=3e-66]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=238, Expect=4e-67]} {RNA1509_38781} {RNA1310_35456} {RNA815_22108} Mlig455_069301 {REF} {Length: 2370} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=178.1]; Nitrate and nitrite sensing [PF08376.12, score=82.3]; Heme NO binding associated [PF07701.16, score=28.0]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=232, Expect=2e-64]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [Score=232, Expect=1e-64]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=225, Expect=5e-62]} {Dmel: FBgn0053958, CG33958, [Score=250, Expect=5e-73]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=223, Expect=1e-61]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=221, Expect=4e-61]} {RNA1509_38781} {RNA1310_35456} {RNA815_24181} |
97. | MligTC455_35259 | 2265 | 47.19 | Mlig455_040978 | Neo: - Age: Up-Down-Down Region-specific R2: 2.606 Region-enriched R2: 1.588/0.00387 |
ADGRL2 | 4.456 | - | 0.766 | 0.846 | 0.978 | 0.878 | 0.988 | Mlig455_040978 {REF} {Length: 10808} {TRANSSPLICED} {Pfam: PDZ domain [PF00595.26, score=86.9]; 7 transmembrane receptor (Secretin family) [PF00002.26, score=76.2]; PDZ domain [PF17820.3, score=67.3]; GPCR proteolysis site, GPS, motif [PF01825.23, score=52.3]; PDZ domain [PF13180.8, score=36.4]; ZU5 domain [PF00791.22, score=30.8]; Guanylate kinase [PF00625.23, score=22.4]} {Human: ENSG00000117114, ADGRL2, adhesion G protein-coupled receptor L2, [RH, Score=174, Expect=1e-42]} {Mouse: ENSMUSG00000034917, Tjp3, tight junction protein 3, [RH, Score=172, Expect=9e-43]} {Dmel: FBgn0262614, pyd, polychaetoid, [RH, Score=232, Expect=8e-61]} {Celegans: WBGene00013683, zoo-1, ZO-1 (Zonula Occludens tight junctional protein) Ortholog, [Score=174, Expect=4e-43]} {Smed: dd_Smed_v6_8425_0_1, dd_Smed_v6_8425_0_1, [RH, Score=833, Expect=0.0]} {RNA1509_17602, RNA1509_52679, RNA1509_58629} {RNA1310_236.2, RNA1509_17602, RNA1509_58629} {RNA1509_17602, RNA1509_58629, RNA815_77.1} |
98. | MligTC455_33854 | 41 | 0.85 | Mlig455_031601 | Neo: - Age: - Region-enriched R2: 5.730/0.00808 |
4.452 | 0.918 | - | 0.866 | 0.783 | 0.907 | 0.978 | Mlig455_031601 {REF} {Length: 1072} {RNA1310_42312} {RNA815_56269} | |
99. | MligTC455_44025 | 591 | 12.31 | Mlig455_050980 | Neo: - Age: - Region-specific R2: 5.366 Region-enriched R2: 5.986/0.00000 |
4.451 | 0.964 | 0.967 | 0.937 | 0.733 | - | 0.850 | Mlig455_050980 {REF} {Length: 587} {Smed: dd_Smed_v6_2575_0_1, dd_Smed_v6_2575_0_1, [Score=49.7, Expect=7e-09]} {RNA1509_52032} {RNA1310_52449.2} {RNA815_56904} | |
100. | MligTC455_19908 | 490 | 10.21 | Mlig455_047266, Mlig455_047318, Mlig455_069346 | Neo: - Age: logFC(26M/2M)=0.566 |
4.451 | 0.735 | - | 0.916 | 0.913 | 0.892 | 0.995 | Mlig455_047266 {REF} {Length: 1728} {Pfam: Glycine rich protein [PF12810.9, score=49.4]} {RNA1509_28009} {RNA1310_17226} {RNA815_32720} Mlig455_047318 {REF} {Length: 2268} {Pfam: Glycine rich protein [PF12810.9, score=36.7]} {RNA1509_28009} {RNA1310_17226, RNA1509_28009} {RNA1509_28009, RNA815_32720} Mlig455_069346 {REF} {Length: 1953} {Pfam: Glycine rich protein [PF12810.9, score=31.6]} {RNA1509_28009} {RNA1310_17226} {RNA815_32720} |